PHAT PRESS-RELEASE SEC Filing Analysis

Latest settled — T+20d

PHAT ▼ -23.06% at T+20d

NEUTRAL call ✗ call lost -23.06% · α vs SPY -28.35% · entry $12.01 → $9.24

Next anchor: T+60d in 6w

Last close $10.37 (close Jun 12) · -13.66% from $12.01 entry

Entry anchored
Apr 30, 03:59 PM ET
via Databento tick

T+1d

+7.16%

call +7.16% · α +7.50%

$12.87

settled 6w ago

T+5d

+1.83%

call +1.83% · α -0.52%

$12.23

settled 5w ago

T+20d

-23.06%

call -23.06% · α -28.35%

$9.24

settled 14d ago

T+60d

—

call — · α —

—

in 6w

Price Chart

Loading chart...

Executive Summary

Phathom Pharmaceuticals announced its participation in the Digestive Disease Week (DDW) 2026 annual meeting, including a product theater presentation for VOQUEZNA and three poster presentations. This is a routine conference attendance with no material financial or regulatory impact.

Actionable Insight

Routine conference participation with no material data releases expected. Monitor for any significant data readouts or regulatory updates in future filings.

Key Facts

Phathom will participate in DDW 2026 (May 2-5, Chicago) with a product theater presentation on VOQUEZNA on May 4.
The company will present three posters covering clinical, patient-reported, and real-world data for VOQUEZNA in GERD.
Poster abstracts will be available on the company website after the meeting.

Financial Impact

No financial impact from this announcement.

Risk Factors

No specific risks identified from this announcement.

Market Snapshot

Exchange

Nasdaq

Sector

Pharmaceutical Preparations

Analyst Consensus

88% bullish (17 analysts)

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

Document	Accession Number
PRESS-RELEASE Data (Synthetic)	press-3285869

5 reports for PHAT

T+1T+5T+20T+60

Track record builds as more directional reports settle.

Filters

Reports for PHAT — sortable, filterable
	Type				Now
May 20, 2026 25d ago	Press Release NEUTRAL ★ 3/10	$11.87 $10.74	▼ −9.52%	▼ −10.76%	$10.37 (−12.64%)
May 1, 2026 6w ago	Press Release NEUTRAL ★ 1/10	$12.01 $12.23	▲ +1.83%	▼ −0.52%	$10.37 (−13.66%)
Apr 30, 2026 6w ago	Press Release MIXED ★ 5/10	$11.20 $12.67	▲ +13.13%	▲ +11.40%	$10.37 (−7.41%)
Apr 7, 2026 9w ago	DEFA14A NEUTRAL ★ 3/10	$11.55 $12.67	▲ +9.70%	▲ +4.37%	$10.37 (−10.22%)
Feb 26, 2026 15w ago	8-K BULLISH ★ 8/10	$13.56 $10.74	▼ −20.80%	▼ −19.67%	$10.37 (−23.53%)

US Market Status

Market Closed — Opens in 5h 15m

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access